According to the latest filings submitted to the U.S. Securities and Exchange Commission (SEC), some shareholders of the biopharmaceutical company ADC Therapeutics SA may gradually sell their holdings of the company's common stock over a period of time, with the total amount reaching up to 9,834,776 shares.
According to the latest filings submitted to the U.S. Securities and Exchange Commission (SEC), some shareholders of the biopharmaceutical company ADC Therapeutics SA may gradually sell their holdings of the company's common stock over a period of time, with the total amount reaching up to 9,834,776 shares.
Show original
Such secondary market offerings initiated by existing shareholders typically do not bring new financing to the company. Market participants will closely monitor the subsequent actual sales to assess their potential impact on the stock price.
0
0
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
PoolX: Earn new token airdrops
Lock your assets and earn 10%+ APR
Lock now!
You may also like
WTI Crude Oil Plunges Over 5% Intraday, IEA Proposes Releasing Its Largest-Ever Oil Reserves
BlockBeats•2026/03/11 00:20
xStocks launches xPoints rewards program
Odaily星球日报•2026/03/11 00:06
Societe Generale's euro stablecoin EURCV expands to the Stellar network
PANews•2026/03/11 00:06
Trending news
MoreCrypto prices
More
Bitcoin
BTC
$69,990.59
+1.86%
Ethereum
ETH
$2,037.13
+1.57%
Tether USDt
USDT
$1
-0.01%
BNB
BNB
$642.93
+0.97%
XRP
XRP
$1.39
+1.53%
USDC
USDC
$1
-0.02%
Solana
SOL
$85.78
+0.66%
TRON
TRX
$0.2857
+0.06%
Dogecoin
DOGE
$0.09456
+4.29%
Cardano
ADA
$0.2615
+2.19%
How to buy BTC
Bitget lists BTC – Buy or sell BTC quickly on Bitget!
Trade now
Become a trader now?A welcome pack worth 6200 USDT for new users!
Sign up now